Fulcrum Therapeutics Inc FULC:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:25 PM EDT
7.64quote price arrow up+0.36 (+4.95%)
Volume
68,744
Close
7.28quote price arrow down-0.16 (-2.15%)
Volume
279,310
52 week range
2.43 - 13.70
Loading...
  • Open7.42
  • Day High7.44
  • Day Low7.18
  • Prev Close7.44
  • 52 Week High13.70
  • 52 Week High Date03/06/24
  • 52 Week Low2.43
  • 52 Week Low Date05/01/23

Key Stats

  • Market Cap450.888M
  • Shares Out61.94M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta2.33
  • YTD % Change7.85

KEY STATS

  • Open7.42
  • Day High7.44
  • Day Low7.18
  • Prev Close7.44
  • 52 Week High13.70
  • 52 Week High Date03/06/24
  • 52 Week Low2.43
  • 52 Week Low Date05/01/23
  • Market Cap450.888M
  • Shares Out61.94M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta2.33
  • YTD % Change7.85

RATIOS/PROFITABILITY

  • EPS (TTM)-1.59
  • P/E (TTM)-4.58
  • Fwd P/E (NTM)-4.08
  • EBITDA (TTM)-108.425M
  • ROE (TTM)-44.84%
  • Revenue (TTM)2.805M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-3,470.05%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Fulcrum Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. The Company’s clinical product candidate, losmapimod, is developed for the potential treatment of facioscapulohumeral muscular dystrophy (FSHD). Its other clinical product candidate is FTX-6058, which is developed for the treatment of certain hemoglobinopathies, including...
Kate Haviland
Independent Chairman of the Board
Alex Sapir
President, Chief Executive Officer, Director
Alan Musso CPA
Chief Financial Officer, Treasurer
Address
26 Landsdowne Street
Cambridge, MA
02139
United States

Top Peers

SYMBOLLASTCHG%CHG
IGMS
IGM Biosciences Inc
7.96+0.26+3.38%
LBPH
Longboard Pharmaceuticals Inc
19.75-0.52-2.57%
OCS
Oculis Holding AG
11.98+0.01+0.08%
LRMR
Larimar Therapeutics Inc
6.46UNCHUNCH
CRBP
Corbus Pharmaceuticals Holdings Inc
35.54-2.20-5.83%